Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Simvastatin acts synergistically with ACE inhibitors or amlodipine to decrease oxygen consumption in rat hearts.

S Mital1, A Magneson, K E Loke

  • 1Division of Pediatric Cardiology, College of Physicians and Surgeons, Columbia University, New York, USA.

Journal of Cardiovascular Pharmacology
|August 15, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer.

NPJ breast cancer·2026
Same author

Evidence for a Spectral Break or Curvature in the Spectrum of Astrophysical Neutrinos from 5 TeV to 10 PeV.

Physical review letters·2026
Same author

Oral Pain and Alzheimer's Disease: Prospective Cohort and Cross-Sectional Analyses.

Journal of dental research·2026
Same author

[Research progress in dental pulp assessment and diagnosis systems for pulpitis].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2025
Same author

Search for Extremely-High-Energy Neutrinos and First Constraints on the Ultrahigh-Energy Cosmic-Ray Proton Fraction with IceCube.

Physical review letters·2025
Same author

Antithrombotic Effect of Ginkgo Biloba Extract: A Study Based on Network Pharmacological Analysis and In vivo Experiments.

Nigerian journal of clinical practice·2025

Short-term simvastatin treatment in rats enhances nitric oxide (NO)-mediated regulation of myocardial oxygen consumption (MV(O2)). This effect potentiates interventions like ACE inhibitors and amlodipine, improving NO-mediated cardiovascular responses.

Area of Science:

  • Cardiovascular Pharmacology
  • Endothelial Function
  • Nitric Oxide Signaling

Background:

  • Statins, cholesterol-lowering drugs, can increase nitric oxide synthase (eNOS) activity in endothelial cells independently of lipid reduction.
  • The impact of short-term statin use on nitric oxide (NO)-mediated regulation of myocardial oxygen consumption (MV(O2)) requires further investigation.

Purpose of the Study:

  • To investigate the effect of short-term simvastatin administration on NO-mediated regulation of MV(O2) in rat heart tissue.
  • To determine if simvastatin influences the NO-dependent responses to bradykinin, ACE inhibitors, and amlodipine.

Main Methods:

  • Male Wistar rats received either a control diet or simvastatin (20 mg/kg/day) orally for two weeks.
  • Isolated left ventricular myocardium was used to measure MV(O2) via a Clark-type oxygen electrode.

Related Experiment Videos

  • Aortic plasma nitrates and nitrites (NOx) were measured; NO-dependent responses to pharmacological agents were assessed.

    • Main Results:

    • No significant differences in baseline plasma NOx or MV(O2) were observed between control and simvastatin groups.
    • Simvastatin treatment significantly augmented the NO-dependent regulation of MV(O2) in response to bradykinin, ramipril (an ACE inhibitor), and amlodipine.
    • The NO donor S-nitroso N-acetyl penicillamine (SNAP) showed similar effects in both groups, indicating simvastatin's action is upstream of direct NO donation.

    Conclusions:

    • Short-term simvastatin administration in rats potentiates the NO-mediated regulation of myocardial oxygen consumption.
    • This potentiation enhances the effects of ACE inhibitors and amlodipine on NO-mediated MV(O2) regulation.
    • Simvastatin may improve cardiovascular function through mechanisms involving enhanced NO signaling pathways.